Lexaria Bioscience Corp. financial statements
Lexaria Bioscience Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 705.92K | 10-K |
| Net income | −USD 11.9M | 10-K |
| Cash and equivalents | USD 1.8M | 10-Q |
Lexaria Bioscience Corp. financials on 6ix · Lexaria Bioscience Corp. on 6ix